CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-23 | Yonehiro Grant Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-07-23 | Quinn William P. President, CEO and CFO | Grant or award · Stock Option (Right to Buy) | +440,000 | 440,000 | ||
| 2024-07-23 | Nemec Sarah VP, Finance and PAO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-07-23 | Nemec Sarah VP, Finance and PAO | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-06-12 | SHAH MAHENDRA Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | ONETTO NICOLE Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | O'CALLAGHAN BRIAN Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | Lee Frank D. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-12 | Berner Laura Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-06 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +2,500 | $0.64 | $2K | 13,863 |
| 2024-06-06 | Quinn William P. President, CEO and CFO | Purchase | +2,500 | $0.64 | $2K | 38,772 |
| 2024-03-04 | Yonehiro Grant Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2024-03-04 | Perez Edith A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2024-03-04 | Schatzman Randall C Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +654,000 | 235,000 | ||
| 2024-03-04 | Quinn William P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2023-12-12 | Quinn William P. Chief Financial Officer | Purchase | +7,500 | $0.95 | $7K | 36,272 |
| 2023-12-06 | Quinn William P. Chief Financial Officer | Purchase | +2,500 | $0.78 | $2K | 28,772 |
| 2023-11-30 | ENGLEMAN EDGAR Director | Sale | −108,145 | $0.86 | $93K | 1,821,483 |
Page 9 of 17 · 337 trades